Content Type: Research Publications

Six-Month Market Exclusivity Extensions to Promote Research Offer Substantial Returns for Many Drug Makers

March 15, 2026

The Real‐World Ethics of Adaptive‐design Clinical Trials

March 15, 2026

Clinical Evidence Supporting US Food and Drug Administration Premarket Approval of High‐risk Otolaryngologic Devices, 2000‐2014

March 15, 2026

Strategies That Delay Market Entry of Generic Drugs

March 15, 2026

Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence

March 15, 2026

Determinants of Market Exclusivity for Prescription Drugs in the United States

March 15, 2026

Clinical Evidence Supporting US Food and Drug Administration Approval of Otolaryngologic Prescription Drug Indications, 2005‐2014

March 15, 2026

Trends in Pricing and Generic Competition Within the Oral Antibiotic Drug Market in the United States

March 15, 2026

Using Antitrust Law to Challenge Turing’s Daraprim Price Increase

March 15, 2026

Comparison of Rates of Safety Issues and Reporting of Trial Outcomes for Medical Devices Approved in the European Union and United States: Cohort Study

March 15, 2026

Protecting Pharmaceutical Patents and Test Data: How the Trans-Pacific Partnership Agreement Could Affect Access to Medicines in the US and Abroad

March 15, 2026

Temporal Trends and Factors Associated with Cardiovascular Drug Development, 1990 to 2012

March 15, 2026